DVT/PE Flashcards
Risk favtors for DVT/PE
Virchow’s Triad: Endothelial injury, venous stasis, hypercoagulable state
Medical DVT prophylaxis:
heparin, enoxaparin (Lovenox), other LMWH (fondaparinux)
For CKD: heparin - others have renal clearance!
For cancer: Lovenox
Complications,
Contraindications of anticoag:
Complications: Bleeding, skin necrosis, HIT
Contraindications: bleeding risk, liver disease, severe HTN, surgery/trauma, pregnancy (use warfarin)
HIT =
Heparin Induced Thrombocytopenia: 5-10days after heparin, Platelets drop >50%
4Ts: Timing, Thrombocytopenia, Thrombosis, alTernative cause
Treatment of HIT:
`1. Stop heparin
2. Direct thrombin inhibitors: argatroban, lepirudin, danapariod (no antidote for these)
Protamine is:
Antidote for heparin and LMWH
Risk assessment via what scoring system
Well’s Criteria
Geneva score
Labs for DVT:
If low risk - DDimer
If med/high risk: ultrasound
Labs for PE:
If low risk - DDimer
If med/high risk or positive DDimer: Spiral CT/CTA
If contrast allergy or CKD and med/high risk: V/Q scan
If preg: CXR and or V/Q scan
Treatment for DVT short term and long term:
- Short term: heparin/lovenox. Heparin for CKD, Lovenox for cancer.
- Long term: Warfarin - start in hospital
Monitoring heparin and warfarin:
Heparin: frequent, PTT, platelet count.
Warfarin:: PT/INR, goal INR=2-3
Anticoagulation duration fir DVT/PE:
1st, provoked: 3months
1st, unprovoked: 6months
2 or thrombophelia: indefinite
cancer: until cancer gone
PE treatment for hemodynamically stable and unstable:
Stable: Anticoag same as DVT, do IVC filter if can’t anticoag.
Unstable: Thrombolysis, surgery if refractory to thrombolysis.
Complications of DVT:
- Post-thrombotic syndrome: venous insufficiency despite anticoag (50% of pts)
- Compartment Syndrome
- PE
Complications of PE
- Pulmonary HTN
- Arrythmias
- Increase all cause mortality.